Description
The Kidney in Heart Failure, 2012
Coordinator: Bakris George L.
Language: English
Subjects for The Kidney in Heart Failure:
Keywords
Publication date: 08-2014
250 p. · 15.5x23.5 cm · Paperback
Publication date: 07-2012
250 p. · 15.5x23.5 cm · Hardback
Description
/li>Contents
/li>Biography
/li>Comment
/li>
Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death. The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.
The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart. This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management. In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included. Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.
This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.
Chapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure
Ruth C. Campbell and Ali Ahmed
Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients:
What is the best way to achieve and what is the desired hemoglobin?
Tejas V. Patel and Ajay K. Singh
Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart FailureIvana Lazich and George L. Bakris
Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS BlockadeMohammed Shakaib and George L. Bakris
Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient
Biff F. Palmer
Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications
Ivan D. Hanson and Peter A. McCullough
Part Three Management of Kidney Associated Clinical Problems
Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure
Julian Segura and Luis M. Ruilope
Chapter 8 Management of Heart Failure with Renal Artery Ischaemia
Andrew K. Roy and Patrick Murray
Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure
Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir
Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment OptionsDomenic A. Sica
Chapter 11 Ultrafiltration and Heart Failure
Paul Chacko, Donald Kikta Jr., William T. Abraham
Part Four Advances in Nephropathy Management: Influences on CVD Risk
Chapter 12 Combination Therapy in Hypertension Treatment
Raymond V. Oliva and George L. Bakris
Chapter 13 Medication Adherence in Heart Failure
Daniel E. Hilleman and Jennifer A. Campbell
Chapter 14 New Markers of Vascular Risk
David Davidson and Michael H. Davidson
Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD
Raghu V. Durvasula and Katherine R. Tuttle
PrefacePart One EpidemiologyChapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure
Ruth C. Campbell and Ali Ahmed
Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients:
What is the best way to achieve and what is the desired hemoglobin?
Tejas V. Patel and Ajay K. Singh
Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart FailureIvana Lazich and George L. Bakris
Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS BlockadeMohammed Shakaib and George L. Bakris
Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient
Biff F. Palmer
Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications
Ivan D. Hanson and Peter A. McCullough
Part Three Management of Kidney Associated Clinical Problems
Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure
Julian Segura and Luis M. Ruilope
Chapter 8 Management of Heart Failure with Renal Artery Ischaemia
Andrew K. Roy and Patrick Murray
Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure
Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir
Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment OptionsDomenic A. Sica
Chapter 11 Ultrafiltration and Heart Failure
Paul Chacko, Donald Kikta Jr., William T. Abraham
Part Four Advances in Nephropathy Management: Influences on CVD Risk
Chapter 12 Combination Therapy in Hypertension Treatment
Raymond V. Oliva and George L. Bakris
Chapter 13 Medication Adherence in Heart Failure
Daniel E. Hilleman and Jennifer A. Campbell
Chapter 14 New Markers of Vascular Risk
David Davidson and Michael H. Davidson
Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD
Raghu V. Durvasula and Katherine R. Tuttle
Ivana Lazich and George L. Bakris
Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS BlockadeMohammed Shakaib and George L. Bakris
Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient
Biff F. Palmer
Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications
Ivan D. Hanson and Peter A. McCullough
Part Three Management of Kidney Associated Clinical Problems
Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure
Julian Segura and Luis M. Ruilope
Chapter 8 Management of Heart Failure with Renal Artery Ischaemia
Andrew K. Roy and Patrick Murray
Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure
Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir
Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment OptionsDomenic A. Sica
Chapter 11 Ultrafiltration and Heart Failure
Paul Chacko, Donald Kikta Jr., William T. Abraham
Part Four Advances in Nephropathy Management: Influences on CVD Risk
Chapter 12 Combination Therapy in Hypertension Treatment
Raymond V. Oliva and George L. Bakris
Chapter 13 Medication Adherence in Heart Failure
Daniel E. Hilleman and Jennifer A. Campbell
Chapter 14 New Markers of Vascular Risk
David Davidson and Michael H. Davidson
Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD
Raghu V. Durvasula and Katherine R. Tuttle
Mohammed Shakaib and George L. Bakris
Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient
Biff F. Palmer
Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications
Ivan D. Hanson and Peter A. McCullough
Part Three Management of Kidney Associated Clinical Problems
Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure
Julian Segura and Luis M. Ruilope
Chapter 8 Management of Heart Failure with Renal Artery Ischaemia
Andrew K. Roy and Patrick Murray
Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure
Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir
Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment OptionsDomenic A. Sica
Chapter 11 Ultrafiltration and Heart Failure
Paul Chacko, Donald Kikta Jr., William T. Abraham
Part Four Advances in Nephropathy Management: Influences on CVD Risk
Chapter 12 Combination Therapy in Hypertension Treatment
Raymond V. Oliva and George L. Bakris
Chapter 13 Medication Adherence in Heart Failure
Daniel E. Hilleman and Jennifer A. Campbell
Chapter 14 New Markers of Vascular Risk
David Davidson and Michael H. Davidson
Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD
Raghu V. Durvasula and Katherine R. Tuttle
Dr. Bakris is currently Professor of Medicine and Director of the Hypertension Center at the University of Chicago Pritzker School of Medicine. Dr. Bakris has published over 600 articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of eight books, in the areas of Kidney Disease Progression and Diabetes. Additionally, he is the Associate Editor of the International Textbook of Cardiology. He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000). He has also served on many national guideline committees including: JNC VI and 7 writing committees, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline Committee. Dr. Bakris is also the past-president of the American College of Clinical Pharmacologyand the current President of the American Society of Hypertension (ASH)(2010-2012). He is the current Editor of American Journal of Nephrology and Hypertension, Section Editor of Up-to-Date and Associate Editor of Diabetes Care and Nephrology, Dialysis & Transplant.
Few published books on this topic
Complete coverage of topic
Contributions by cardiologists and nephrologists
These books may interest you
Uremic Toxins and Organ Failure 105.49 €
Uremic Toxins and Organ Failure 105.49 €